Detailed Information for C00571

Basic information about inhibitors

IPAD-DB ID C00571
Name Onjisaponin B
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 7 5 H 1 1 2 O 3 5
Molecular Weight 1573.7 g/mol
IUPAC Name (2S, 3R, 4S, 4aR, 6aR, 6bR, 8aS, 12aS, 14aR, 14bR)-8a-[(2S, 3R, 4S, 5S, 6R)-3-[(2S, 3R, 4S, 5R, 6S)-5-[(2S, 3R, 4R, 5R)-3, 4-dihydroxy-5-[(2S, 3R, 4S, 5R, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3, 4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy-6-methyl-4-[(2S, 3R, 4R, 5R, 6S)-3, 4, 5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4, 6a, 11, 11, 14b-pentamethyl-3-[(2R, 3R, 4S, 5S, 6R)-3, 4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1, 2, 3, 4a, 5, 6, 7, 8, 9, 10, 12, 12a, 14, 14a-tetradecahydropicene-4-carboxylic acid
InChI InChI=1S/C75H112O35/c1-30-44(81)48(85)53(90)63(99-30)107-59-58(105-43(80)17-12-33-10-13-34(97-9)14-11-33)32(3)101-67(60(59)108-64-56(93)51(88)57(31(2)100-64)106-62-52(89)47(84)40(28-98-62)104-65-54(91)49(86)45(82)38(26-76)102-65)110-69(96)74-21-20-70(4, 5)24-36(74)35-15-16-41-71(6)25-37(79)61(109-66-55(92)50(87)46(83)39(27-77)103-66)73(8, 68(94)95)42(71)18-19-72(41, 7)75(35, 29-78)23-22-74/h10-15, 17, 30-32, 36-42, 44-67, 76-79, 81-93H, 16, 18-29H2, 1-9H3, (H, 94, 95)/b17-12+/t30-, 31-, 32+, 36-, 37-, 38+, 39+, 40+, 41+, 42+, 44-, 45-, 46+, 47-, 48+, 49-, 50-, 51-, 52+, 53+, 54+, 55+, 56+, 57-, 58-, 59-, 60+, 61-, 62-, 63-, 64-, 65-, 66-, 67-, 71+, 72+, 73-, 74-, 75-/m0/s1
InChIKey QSTBHNPMHXYCII-KJCIHCEPSA-N
Canonical SMILES CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)C)OC4C(C(C(CO4)OC5C(C(C(C(O5)CO)O)O)O)O)O)O)O)OC(=O)C67CCC(CC6C8=CCC9C(C8(CC7)CO)(CCC1C9(CC(C(C1(C)C(=O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C)C)(C)C)C)OC(=O)C=CC1=CC=C(C=C1)OC)O)O)O
PubChem CID 21669942
DrugBank Accession Number -
CAS Registry Number -

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein
Effects Reduce Aβ production, promote APP degradation, ameliorate cognitive impairments in APP/PS1 mice
Research Models In APP/PS1 mice, in HEK293T, HEK293, HEK293MSR and A431 cells, in vitro
Main Source Radix Polygalae
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)
Hac(Computed by SwissADME)
Volume(Computed by ADMETlab 2.0) 1489.644
Density(Computed by ADMETlab 2.0) 1.056
nRing(Computed by ADMETlab 2.0) 12
MaxRing(Computed by ADMETlab 2.0) 22
nHet(Computed by ADMETlab 2.0) 35
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 72
Flexibility(Computed by ADMETlab 2.0) 0.306
Stero Centers(Computed by ADMETlab 2.0) 39
LogS(Computed by ADMETlab 2.0) -1.831
LogD(Computed by ADMETlab 2.0) 1.379

ADMET properties

logP(Computed by ADMETlab 2.0) -0.318
TPSA(Computed by SwissADME)
Hbond Acceptor(Computed by SwissADME)
Hbond Donor(Computed by SwissADME)
Rotatable Bonds(Computed by SwissADME)

Pharmacokinetics

GI Absorption(Computed by SwissADME)
BBB(blood-brain barrier) Permeant(Computed by SwissADME)
P-gp Substrate(Computed by SwissADME)
CYP1A2 Inhibitor(Computed by SwissADME)
CYP2C19 Inhibitor(Computed by SwissADME)
CYP2C9 Inhibitor(Computed by SwissADME)
CYP2D6 Inhibitor(Computed by SwissADME)
CYP3A4 Inhibitor(Computed by SwissADME)
log Kp(Skin Permeation)(Computed by SwissADME)

Druglikeness

Lipinski(Computed by SwissADME)
Ghose(Computed by SwissADME)
Veber(Computed by SwissADME)
Egan(Computed by SwissADME)
Muegge(Computed by SwissADME)
Bioavailability Score(Computed by SwissADME)